HK
Hemil Kirti Shah
About Hemil Kirti Shah
Data last updated:
Hemil Kirti Shah has 8 years in corporate governance. Holds Designated Partner role. Currently with 3 companies, including Hiyana Pharmaceuticals India Llp and Prahem Laboratories Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Prahem Laboratories Llp at ₹54.97 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 27 Aug 2018 | 2018 | ₹54.97 Cr (FY 2024) | Active | |
| Designated Partner | 31 Mar 2023 | 2023 | – | Active | |
| Designated Partner | 09 Jul 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemil Kirti Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemil Kirti Shah
Hemil Kirti Shah has 8 years in corporate governance. Holds Designated Partner role. Currently with 3 companies, including Hiyana Pharmaceuticals India Llp and Prahem Laboratories Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Prahem Laboratories Llp at ₹54.97 Cr (FY 2024).
Hemil Kirti Shah is associated with 3 companies as Designated Partner, including Prahem Laboratories Llp (₹54.97 Cr), Ishpra Pharma Llp, Hiyana Pharmaceuticals India Llp.
Hemil Kirti Shah has expertise in General Business.
Hemil Kirti Shah has 8 years in corporate governance.
By reported revenue, the largest current company of Hemil Kirti Shah is Prahem Laboratories Llp, with revenue of ₹54.97 Cr (FY 2024).
Hemil Kirti Shah currently holds positions at 3 companies: Prahem Laboratories Llp (₹54.97 Cr), Ishpra Pharma Llp, Hiyana Pharmaceuticals India Llp.